ArticleOncology letters2024

[Retracted] Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P‑glycoprotein and MRPs expression.

Hongchun Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.